phenobarbital will minimize the extent or result of eltrombopag by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Check.Steer clear of; coadministration with CYP3A inducers may result in lowered plasma concentrations of elvitegravir and/or a concomitantly administered protease inhibitor and cause loss of therapeutic influence also to … Read More